vs
Side-by-side financial comparison of Bioceres Crop Solutions Corp. (BIOX) and COMSCORE, INC. (SCOR). Click either name above to swap in a different company.
COMSCORE, INC. is the larger business by last-quarter revenue ($93.5M vs $77.6M, roughly 1.2× Bioceres Crop Solutions Corp.). COMSCORE, INC. runs the higher net margin — 3.2% vs -9.6%, a 12.8% gap on every dollar of revenue. On growth, COMSCORE, INC. posted the faster year-over-year revenue change (-1.5% vs -16.8%). Over the past eight quarters, COMSCORE, INC.'s revenue compounded faster (3.8% CAGR vs -8.4%).
Bioceres Crop Solutions Corp is a global agricultural technology firm that develops and commercializes sustainable crop solutions including drought-tolerant seed traits, biofertilizers, and biopesticides. It serves farmers across South America, North America, Europe and Asia-Pacific, focusing on raising crop yields while reducing the environmental footprint of agricultural activities.
Comscore, Inc. is an American-based global media measurement and analytics company providing marketing data and analytics to enterprises, advertising agencies, brand marketers, and publishers.
BIOX vs SCOR — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $77.6M | $93.5M |
| Net Profit | $-7.4M | $3.0M |
| Gross Margin | 46.8% | 41.0% |
| Operating Margin | 9.3% | 7.0% |
| Net Margin | -9.6% | 3.2% |
| Revenue YoY | -16.8% | -1.5% |
| Net Profit YoY | -20.2% | -3.7% |
| EPS (diluted) | $-0.12 | $9.50 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $93.5M | ||
| Q3 25 | $77.6M | $88.9M | ||
| Q2 25 | — | $89.4M | ||
| Q1 25 | $60.6M | $85.7M | ||
| Q4 24 | $98.8M | $94.9M | ||
| Q3 24 | $93.3M | $88.5M | ||
| Q2 24 | — | $85.8M | ||
| Q1 24 | $84.0M | $86.8M |
| Q4 25 | — | $3.0M | ||
| Q3 25 | $-7.4M | $453.0K | ||
| Q2 25 | — | $-9.5M | ||
| Q1 25 | $-1.6M | $-4.0M | ||
| Q4 24 | $605.2K | $3.1M | ||
| Q3 24 | $-6.2M | $-60.6M | ||
| Q2 24 | — | $-1.7M | ||
| Q1 24 | $9.8M | $-1.1M |
| Q4 25 | — | 41.0% | ||
| Q3 25 | 46.8% | 40.6% | ||
| Q2 25 | — | 40.6% | ||
| Q1 25 | 39.4% | 39.6% | ||
| Q4 24 | 42.0% | 42.4% | ||
| Q3 24 | 40.2% | 41.2% | ||
| Q2 24 | — | 39.5% | ||
| Q1 24 | 50.8% | 42.3% |
| Q4 25 | — | 7.0% | ||
| Q3 25 | 9.3% | 1.9% | ||
| Q2 25 | — | -1.9% | ||
| Q1 25 | 1.5% | -2.4% | ||
| Q4 24 | 14.5% | 4.1% | ||
| Q3 24 | 2.5% | -67.4% | ||
| Q2 24 | — | -2.2% | ||
| Q1 24 | 15.7% | -2.2% |
| Q4 25 | — | 3.2% | ||
| Q3 25 | -9.6% | 0.5% | ||
| Q2 25 | — | -10.6% | ||
| Q1 25 | -2.6% | -4.7% | ||
| Q4 24 | 0.6% | 3.3% | ||
| Q3 24 | -6.6% | -68.5% | ||
| Q2 24 | — | -2.0% | ||
| Q1 24 | 11.6% | -1.2% |
| Q4 25 | — | $9.50 | ||
| Q3 25 | $-0.12 | $-0.86 | ||
| Q2 25 | — | $-2.73 | ||
| Q1 25 | $-0.02 | $-1.66 | ||
| Q4 24 | $0.00 | $-0.47 | ||
| Q3 24 | $-0.10 | $-12.79 | ||
| Q2 24 | — | $-1.19 | ||
| Q1 24 | $0.14 | $-1.08 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $15.5M | $23.6M |
| Total DebtLower is stronger | — | $41.5M |
| Stockholders' EquityBook value | $288.3M | $111.4M |
| Total Assets | $734.9M | $407.7M |
| Debt / EquityLower = less leverage | — | 0.37× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $23.6M | ||
| Q3 25 | $15.5M | $26.7M | ||
| Q2 25 | — | $26.0M | ||
| Q1 25 | $38.5M | $31.0M | ||
| Q4 24 | $29.2M | $29.9M | ||
| Q3 24 | $32.3M | $20.0M | ||
| Q2 24 | — | $14.7M | ||
| Q1 24 | $16.4M | $18.7M |
| Q4 25 | — | $41.5M | ||
| Q3 25 | — | $41.4M | ||
| Q2 25 | — | $41.3M | ||
| Q1 25 | — | $41.3M | ||
| Q4 24 | — | $41.2M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | — | $111.4M | ||
| Q3 25 | $288.3M | $-26.3M | ||
| Q2 25 | — | $-21.7M | ||
| Q1 25 | $345.0M | $-13.5M | ||
| Q4 24 | $346.3M | $-8.3M | ||
| Q3 24 | $346.0M | $-2.7M | ||
| Q2 24 | — | $45.8M | ||
| Q1 24 | $348.5M | $51.4M |
| Q4 25 | — | $407.7M | ||
| Q3 25 | $734.9M | $406.9M | ||
| Q2 25 | — | $415.9M | ||
| Q1 25 | $798.2M | $421.5M | ||
| Q4 24 | $835.2M | $430.2M | ||
| Q3 24 | $827.3M | $412.5M | ||
| Q2 24 | — | $474.1M | ||
| Q1 24 | $836.1M | $477.7M |
| Q4 25 | — | 0.37× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $14.4M | $3.2M |
| Free Cash FlowOCF − Capex | — | $2.9M |
| FCF MarginFCF / Revenue | — | 3.1% |
| Capex IntensityCapex / Revenue | — | 0.3% |
| Cash ConversionOCF / Net Profit | — | 1.07× |
| TTM Free Cash FlowTrailing 4 quarters | — | $21.8M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $3.2M | ||
| Q3 25 | $14.4M | $9.5M | ||
| Q2 25 | — | $932.0K | ||
| Q1 25 | $23.3M | $9.1M | ||
| Q4 24 | $-5.4M | $-10.0M | ||
| Q3 24 | $5.2M | $12.5M | ||
| Q2 24 | — | $8.7M | ||
| Q1 24 | $-17.4M | $6.9M |
| Q4 25 | — | $2.9M | ||
| Q3 25 | — | $9.4M | ||
| Q2 25 | — | $787.0K | ||
| Q1 25 | — | $8.7M | ||
| Q4 24 | — | $-10.3M | ||
| Q3 24 | — | $12.4M | ||
| Q2 24 | — | $8.5M | ||
| Q1 24 | — | $6.6M |
| Q4 25 | — | 3.1% | ||
| Q3 25 | — | 10.5% | ||
| Q2 25 | — | 0.9% | ||
| Q1 25 | — | 10.1% | ||
| Q4 24 | — | -10.8% | ||
| Q3 24 | — | 14.0% | ||
| Q2 24 | — | 10.0% | ||
| Q1 24 | — | 7.6% |
| Q4 25 | — | 0.3% | ||
| Q3 25 | — | 0.1% | ||
| Q2 25 | — | 0.2% | ||
| Q1 25 | — | 0.4% | ||
| Q4 24 | — | 0.2% | ||
| Q3 24 | — | 0.1% | ||
| Q2 24 | — | 0.2% | ||
| Q1 24 | — | 0.3% |
| Q4 25 | — | 1.07× | ||
| Q3 25 | — | 20.96× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | -8.85× | -3.19× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | -1.78× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
BIOX
Segment breakdown not available.
SCOR
| Transferred Over Time | $77.1M | 83% |
| Research Insight Solutions | $14.6M | 16% |
| Related Party | $2.5M | 3% |
